|  |  | 

India Top Headlines

“There’s no reason states should complain now”: Harsh Vardhan on phase 3 vaccination | India News


NEW DELHI: Union Minister of Health Hard Vardhan on Sunday he said he sees no reason why states should now complain about the freedom they have been given to purchase the vaccine directly from the manufacturers and negotiate prices based on volumes.
In a four-page statement, the Vardhan said the allegation that the Center is getting it cheaply and the states is not “patently false.”

“The 50% quota, which is at the price of the Center, is for the free distribution of vaccines and the distribution of all this will be done only through the states. Therefore, the accusation that the Center is obtaining it from low price and states is not obviously false “. he said.
The minister defended the new strategy according to which all those over 18 years of age will be vaccinated against Covid-19 as of May 1 and attacked those political leaders who indulge in “unnecessary policies” in this regard and spread misinformation.
In the third phase of the national vaccination campaign that will begin next month, vaccine manufacturers would provide 50% of the doses issued monthly by the Central Drug Laboratory (CDL) to the central government and would be free to supply the remaining 50% of the doses to the state. governments and the open market.
In his statement, Vardhan said that several states like Assam, Uttar Pradesh, Madhya Pradesh, Bihar, Maharashtra, Jharkhand, Jammu and Kashmir, Tamil nadu, Himachal Pradesh, Kerala, Chhattisgarh, Haryana, Kerala, Sikkim, West Bengal, Telangana and Andhra Pradesh have already announced that they will vaccinate people between the ages of 18 and 45 against the coronavirus for free.
This is a welcome decision and under the new liberalized policy, they have full freedom to do this, he said.
The Health Ministry previously said that vaccine manufacturers would have to make an advance declaration of the price of the 50 percent supply that would be available to state governments and on the open market before May 1.
Bharat Biotech has priced its COVID-19 vaccine, Covaxinat Rs 600 per dose for state governments and Rs 1200 per dose for private hospitals. Serum Institute of India has announced a price of Rs 400 per dose for “Covishield” for states and Rs 600 per dose for private hospitals. Both vaccines will be available to the central government at Rs 150 per dose.

Reference page